In tough times generic drugs come to the res­cue

Top 100 See - - See Top Industries - By Pavel Gra­matikov

The global fi­nan­cial down­turn and the on­go­ing Euro­pean sov­er­eign debt cri­sis have af­flicted al­most all in­dus­tries and the phar­ma­ceu­ti­cals sec­tor is no ex­cep­tion. Phar­ma­ceu­ti­cal com­pa­nies man­u­fac­tur­ing brand drugs face a tough mar­ket while com­pa­nies mak­ing generic medicines, or cheaper copies of branded drugs with their patent ex­pired or un­der an agree­ment with the branded drug maker, may ben­e­fit from the sit­u­a­tion.

The cou­pling of the cri­sis with the boom in patent ex­pi­ra­tions con­tin­ues to give a strong boost to generic drug mak­ers.

Im­age by fox­u­mon

Newspapers in English

Newspapers from Bulgaria

© PressReader. All rights reserved.